Naproxen and aspirin in rheumatoid arthritis: a multicenter double-blind crossover comparison study.

One hundred nineteen adults with active definite or classical rheumatoid arthritis were studied in a multicenter double-blind crossover study of naproxen (500 mg/day) and aspirin (3.6 Gm/day). Each drug was given in sequence for a six-week study period.